NYSE: BCSFBain Capital Specialty Finance Inc Stock
$14.96+0.36 (+2.47%)
Updated Apr 17, 2025
BCSF Price
$14.96
Fair Value Price
N/A
Market Cap
$965.85M
52 Week Low
$13.20
52 Week High
$19.21
P/E
8.09x
P/B
0.85x
P/S
3.87x
PEG
2.64x
Dividend Yield
6.22%
Revenue
$292.65M
Earnings
$119.42M
Gross Margin
78%
Operating Margin
67.86%
Profit Margin
40.8%
Debt to Equity
1.31
Operating Cash Flow
-$27M
Beta
0.63
Next Earnings
May 5, 2025
Ex-Dividend
Jun 16, 2025
Next Dividend
Jun 30, 2025
BCSF Overview
Bain Capital Specialty Finance, Inc. operates as a business development company (BDC) specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BCSF's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
C
BCSF
Ranked#37 of 85
Ranked#37 of 85
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.63 | B | |
| $14.78 | B | |
| $23.49 | B |
Be the first to know about important BCSF news, forecast changes, insider trades & much more!
BCSF News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BCSF scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BCSF ($14.96) is trading above its intrinsic value of $12.01, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BCSF is good value based on its earnings relative to its share price (8.09x), compared to the US market average (27.98x)
P/E vs Market Valuation
BCSF is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more BCSF due diligence checks available for Premium users.
Valuation
BCSF price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.09x
Industry
33.17x
Market
27.98x
BCSF is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BCSF is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
BCSF price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.85x
Industry
2.52x
BCSF is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BCSF price to earnings growth (PEG)
For valuing profitable companies with growth potential
BCSF is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
BCSF's financial health
Profit margin
Revenue
$73.3M
Net Income
$22.1M
Profit Margin
30.2%
BCSF's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.6B
Liabilities
$1.5B
Debt to equity
1.31
BCSF's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BCSF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$20.0M
Investing
$0.0
Financing
$59.9M
BCSF vs Asset Management Stocks
Bain Capital Specialty Finance Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.